US4359389A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for the purification of interferon
Assignee: Stichting Rega VZW
•
Filing: 1980-10-17
•
Granted: 1982-11-16
•
Expires: 2000-10-17
Abstract
Abstract Human fibroblast interferon may be purified to a high degree by using a simple two-step purification method comprising (a) subjecting an aqueous interferon solution to chromatography on porous glass beads, and (b) subjecting the resulting aqueous interferon solution to chromatography on immobilized zinc chelate. Overall recoveries of about 45-76% of the initial interferon activity may be achieved and the end product will be free of any skin reactive agents.
Inventors
- 👤 Jochen W. Heine
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 07:59
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/52; C07K14/555; C07K14/565; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S435/00; Y10S435/811
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
121 words
A method for the purification of interferon, by chromatography comprising the steps of: (a) contacting an aqueous solution of human fibroblast interferon with porous glass beads at neutral or slightly alkaline pH for selective adsorption of interferon from solution onto the beads; (b) contacting the beads with an elution agent at acidic pH for elution of adsorbed interferon from said beads; (c) collecting a first interferon-containing eluate; (d) contacting said eluate with immobilized zinc chelate at neutral or slightly alkaline pH for selective adsorption of interferon from said eluate onto said zinc chelate; (e) contacting said zinc chelate with an elution agent at acidic pH for elution of interferon from said chelate; and (f) recovering a second eluate containing purified interferon.
Claim 2
Independent Claim
121 words
A method for the purification of interferon, by chromatography comprising the steps of: (a) contacting an aqueous solution of human fibroblast interferon with porous glass beads at neutral or slightly alkaline pH for selective adsorption of interferon from solution onto the beads; (b) contacting the beads with an elution agent at acidic pH for elution of adsorbed interferon from said beads; (c) collecting a first interferon-containing eluate; (d) contacting said eluate with immobilized zinc chelate at neutral or slightly alkaline pH for selective adsorption of interferon from said eluate onto said zinc chelate; (e) contacting said zinc chelate with an elution agent at acidic pH for elution of interferon from said chelate; and (f) recovering a second eluate containing purified interferon.
Claim 3
Dependent Claim
41 words
The method of claim 1, characterized in that the glass beads after adsorption and before elution are washed with a phosphate-buffered saline solution of about neutral pH followed by washing with a buffer solution of lower pH up to pH 3.0.
Claim 4
Dependent Claim
31 words
The method of claim 1, characterized in that the elution agent of step (b) has a pH between 1.5 and 2.7 and an ionic strength between 0.05 M and 0.5 M.
Claim 5
Dependent Claim
25 words
The method of claim 3, characterized in that elution from the glass beads is effected with a 0.3 M glycine-HCl buffer solution of pH 2.0.
Claim 6
Dependent Claim
26 words
The method of claim 1, characterized in that the eluate resulting from step (c) is dialyzed against a phosphate-buffered saline solution for preparation for step (d).
Claim 7
Dependent Claim
23 words
The method of claim 1, characterized in that said immobilized zinc chelate is a chelate of zinc and iminodiacetate coupled to epoxy-activated Sepharose.
Claim 8
Dependent Claim
42 words
The method of claim 1, characterized in that the immobilized zinc chelate after adsorption and before elution is washed with a phosphate-buffered saline solution of about neutral pH followed by washing with a buffer solution of lower pH up to pH 5.9.
Claim 9
Dependent Claim
31 words
The method of claim 1, characterized in that the elution agent of step (e) has a pH between 6.0 and 4.0 and an ionic strength between 0.05 M and 0.5 M.
Claim 10
Dependent Claim
26 words
The method of claim 8, characterized in that elution from the zinc chelate is effected with a 0.1 M sodium acetate solution of pH 4.2 .
Claim 11
Dependent Claim
14 words
The method of claim 1, wherein said zinc chelate is a zinc chelate gel.
Claim 12
Dependent Claim
23 words
The method of claim 1, wherein said porous glass beads have a controlled pore size with an average value of from 170-1700 angstroms.
Claim 13
Dependent Claim
22 words
The method of claim 1, wherein said porous glass beads have a diameter of between about 50 μm and about 500 μm.
Claim 14
Dependent Claim
20 words
The method of claim 1, wherein said aqueous solution of human fibroblast interferon has a pH between 7.0 and 8.2.
Claim 15
Dependent Claim
27 words
The method of claim 1, wherein said immobilized zinc chelate is a chelate of zinc and iminodiacetate coupled to agarose having side chains with terminal epoxy groups.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-11-15 | 1986-05-17 | 1986-11-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-11-15 | 1990-05-17 | 1990-11-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-11-15 | 1994-05-17 | 1994-11-16 | $7700.00 | Window Closed / Lapsed |